Walpar Nutritions Limited (NSE:WALPAR)

India flag India · Delayed Price · Currency is INR
37.00
-1.10 (-2.89%)
At close: Apr 28, 2026
-19.57%
Market Cap 347.45M
Revenue (ttm) 757.46M
Net Income (ttm) 23.31M
Shares Out 9.39M
EPS (ttm) 2.49
PE Ratio 14.89
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,000
Average Volume 3,400
Open 38.15
Previous Close 38.10
Day's Range 37.00 - 38.15
52-Week Range 37.00 - 53.30
Beta -0.42
RSI 34.79
Earnings Date May 15, 2026

About Walpar Nutritions

Walpar Nutritions Limited manufactures and trades pharmaceutical, nutraceutical, herbal, and ayurvedic commodities in India. The company offers G-Flora, a probiotic blend for gut health and immunity; Inosia-F, an inositol supplement; Inovam Plus, a multivitamin; Ironica-CR, controlled-release iron supplement; Myobest, muscle support formula; Ovality, ovarian health support; Ovanyx-F, a female reproductive health supplement; Ovacon-F, women's fertility support; PCOS Care Forte, a PCOS support; Procive-F, female fertility enhancement supplement; ... [Read more]

Industry Pharmaceutical Preparations
Founded 2009
Country India
Stock Exchange National Stock Exchange of India
Ticker Symbol WALPAR
Full Company Profile

Financial Performance

In fiscal year 2025, Walpar Nutritions's revenue was 719.60 million, an increase of 14.93% compared to the previous year's 626.13 million. Earnings were 23.24 million, an increase of 46.92%.

Financial Statements

News

There is no news available yet.